The Endocrine Society is pleased to announce a new initiative in furtherance of its commitment to supporting its global membership and serving endocrine research and clinical communities around the world, through its Global Endocrine Leadership Coalition (GELC).
The Endocrine Society is extending a benefit to GELC member organizations, previously available only to Endocrine Society members, allowing individual members of GELC societies to incur no fees — all page and color charges waived — to publish under a standard license in Endocrinology, the Society’s flagship basic science journal.
Endocrinology the flagship basic science journal of the Endocrine Society, publishes original research articles, mini-reviews, commentaries, brief reports, and technical resources, related to foundational, translational, and preclinical studies investigating endocrine and metabolic function in health and disease at the molecular, biochemical, cellular, genomic, comparative, organismal, and/or environmental levels.
Benefits to GELC Members to Publish in Endocrinology
Global Readership and Article-Level impact
With continuous online-only publication, Endocrinology is read by researchers around the world, ensuring global reach and impact
High-Quality Peer Review
Our journal editors are vetted by the Society for their expertise and adherence to strict publishing standards. They ensure that all manuscripts receive consideration by thought leaders in the field, with rigorous attention to research integrity throughout the peer review and publication process. All Endocrine Society journals follow Committee on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE) standards.
Format Neutral Submission
New manuscripts may be submitted format neutral, as a single Word, RTF, or PDF file. Technical formatting such as reference layout and order of components is not scrutinized for compliance at this initial stage. If the required information is present (complete title page, all author information, abstract, full text, line numbering, figures and tables, references, etc.) the manuscript will be assessed solely on its scientific merit.
Efficient Turnaround
Median of four working days from submission to first editorial decision, and seven working days from a manuscript being accepted, author license signed, and posted online as an Advance Article (non-copyedited) for citation and listing by PubMed.
Journal Metrics and Indexing
Endocrinology is ranked as one of the most authoritative and cited research journals in its field, it is the eighth most-cited journal among 193 journals in the Clarivate category “Endocrinology & Metabolism,” earning more than 33,000 citations in 2024, and has the category’s highest Cited Half-Life with a median of 15.4 years. Impact Factor 2024: 3.3; Scopus CiteScore 2024: 8.1. Indexed by Indexed by CABI, Clarivate, EBSCO, IFIS, OCLC, ProQuest/ExLibris, PubMed, TDNet, and Yewno.
No Page or Color Charges for GELC Members, with an Open Access Option
As a hybrid journal (subscription-based, with open access option), Endocrinology has no page, color, or other charges for articles that include a GELC member in the author group and publish under a standard license. Open access is offered as an optional addition with an Article Processing Charge (APC). Manuscripts declined by Endocrinology that the author agrees to transfer to Journal of the Endocrine Society (JES) for consideration have an APC if accepted for publication in JES.
Learn More
To access these benefits, GELC members – as is already the case for Endocrine Society members – may review the Author Guidelines and submit manuscripts to Endocrinology at https://academic.oup.com/endo, indicating their society affiliation when prompted in the submission interface. Questions? Contact [email protected].
Information on the additional benefits of becoming an individual member of the Endocrine Society, a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries, is available here.
